Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC (CONTACT-02)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04446117 |
Recruitment Status :
Recruiting
First Posted : June 24, 2020
Last Update Posted : October 19, 2020
|
Sponsor:
Exelixis
Collaborators:
Roche-Genentech
Takeda
Information provided by (Responsible Party):
Exelixis
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Recruiting |
---|---|
Estimated Primary Completion Date : | March 30, 2022 |
Estimated Study Completion Date : | July 30, 2023 |